A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

Volunteers are needed to help run a leading sight loss charity support group, which supports people affected by macular ...

On completion of the scans and tests, he said: “You have early age-related macular degeneration ... the sound of a voice to recognise who was there.

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no ...

In the last 20 years, there have been rapid advances in the treatment options for myopic ... it is possible that patients with myopic macular degeneration complicated by CNV may benefit from ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...